This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, and complications in diabetic subjects in Asia.
Study Type
OBSERVATIONAL
Enrollment
1,932
Subject will only fill out a questionaire when entering the observational study
Unnamed facility
Seoul, South Korea
Mean age of onset of type 1 and type 2 diabetes mellitus, respectively
Time frame: at baseline visit/study start
Mean duration of treatment of type 2 diabetes mellitus.
Time frame: at baseline visit/study start
Percentage of patients on insulin and Oral Anti-Diabetics Drugs (OADs) therapy, respectively
Time frame: at baseline visit/study start
Mean duration of diabetes in type 1 and type 2 diabetic patients respectively
Time frame: at baseline visit/study start
Mean FPG (fasting plasma glucose),PPG (post prandial glucose) and HbA1c of diabetic patients.
Time frame: at baseline visit/study start
Percentage of diabetic patients with HbA1c target below 7.0% and below 6.5%, respectively
Time frame: at baseline visit/study start
Percentage of diabetic patients having dyslipidemia and hypertension, cardiovascular complications, peripheral vascular disease, diabetic nephropathy and diabetic eye complications, respectively
Time frame: at baseline visit/study start
Patients' perception will be analysed through patient questionnaire measuring psychological well-being, quality of life and patients' compliant to treatment
Time frame: at baseline visit/study start
Physician perception of diabetes and its management will be analysed through physician questionnaire measuring awareness about: HbA1c test and its goal, anti-diabetic treatment, barriers towards optimum diabetes control
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: at baseline visit/study start
Duration of diabetes associated with highest number of diabetic complications
Time frame: at baseline visit/study start
Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, nephropathy and retinopathy)
Time frame: at baseline visit/study start